Investor · Cambridge, MA

Andrew L. Koven

Open Andrew in the network graph →

Filings

26

SEC Form D

Connections

180

co-filers

Capital

$27.0M

across filings

Active

Mar 2023

to May 2025

Most-connected co-filers (180)

Jason A. Carss · New York, NY8 shared Christopher A. Lee · New York, NY8 shared Sara A. Verkest · New York, NY8 shared Jennifer A. Mcgroarty · New York, NY8 shared Robert N. Antablin · New York, NY8 shared Caleb Smith · West Des Moines, IA8 shared Mary A. Shaw · New York, NY8 shared Kyle N. Matter · New York, NY8 shared Michael A. Longo · New York, NY8 shared Scott A. Karnas · New York, NY8 shared Rachel L. Winokur · New York, NY8 shared Julia Paino · Biddeford, ME8 shared Philip A. Kim · New York, NY8 shared Steven Codispoti · New York, NY8 shared Marshall H. Woodworth · Cambridge, MA7 shared Eric L. Trachtenberg · Milton, Ontario, Canada6 shared Scott J. Charles · Milton, Ontario, Canada6 shared Hyung H. Kim · Cambridge, MA5 shared Amy Lesch · New York, NY5 shared Bernard I. Chiasson · Milton, Ontario, Canada5 shared Murray I. Roach · Milton, Ontario, Canada4 shared Mark Benrus · North Aurora, IL3 shared Joseph W. Beyers · Campbell, CA3 shared Marshall F. Phelps, Jr · Campbell, CA3 shared

Recent filings (26)

CLF I, L.P.Jul 2025 · 11 co-filers MetaVia Inc.May 2025 · 23 co-filers$10.0M MetaVia Inc.May 2025 · 23 co-filers$10.0M CLF I, L.P.Jul 2024 · 11 co-filers NeuroBo Pharmaceuticals, Inc.Jul 2024 · 23 co-filers$17.0M NeuroBo Pharmaceuticals, Inc.Jul 2024 · 23 co-filers$17.0M KKR Global Impact Fund II ESC (Unlev) L.P.Oct 2023 · 18 co-filers KKR Global Impact Fund II SBS L.P.Oct 2023 · 18 co-filers KKR Global Impact Fund II ESC (Lev) L.P.Oct 2023 · 18 co-filers Bakken Energy Income 23-2, LPSep 2023 · 17 co-filers$30.0M KKR Global Impact Fund II Private investors (Offshore B) L.P.Aug 2023 · 17 co-filers KKR Global Impact Fund II Private Investors (Onshore B) L.P.Aug 2023 · 17 co-filers KKR Global Impact Fund II SCSpJul 2023 · 31 co-filers Bakken Energy Income 23-2, LPJun 2023 · 17 co-filers$30.0M KKR Global Impact Fund II (EUR) SCSpMar 2023 · 31 co-filers KKR Global Impact Fund II SCSpMar 2023 · 31 co-filers Midcon Income 23-1, LPMar 2023 · 17 co-filers$60.0M Kala Pharmaceuticals, Inc.Nov 2021 · 27 co-filers$36.5M Kala Pharmaceuticals, Inc.Nov 2021 · 27 co-filers$36.5M NeuroBo Pharmaceuticals, Inc.Oct 2021 · 21 co-filers$14.0M NeuroBo Pharmaceuticals, Inc.Oct 2021 · 21 co-filers$14.0M Spirit RR Holdings, Inc.Jun 2018 · 4 co-filers$133.9M Aralez Pharmaceuticals Inc.Feb 2016 · 27 co-filers$75.0M Aralez Pharmaceuticals Inc.Feb 2016 · 27 co-filers$75.0M Tribute Pharmaceuticals Canada Inc.Feb 2016 · 20 co-filers$75.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Andrew in the interactive graph →